NovaBridge Biosciences (NBP) Depreciation and Depletion (2019 - 2025)

NovaBridge Biosciences (NBP) reported Depreciation and Depletion of $15000.0 for Q4 2025, down 31.82% year-over-year from $22000.0 in Q4 2024, and down 11.76% quarter-over-quarter from $17000.0 in Q3 2025.

NovaBridge Biosciences (NBP) Depreciation and Depletion (2019 - 2025) Analysis & Trends

NovaBridge Biosciences (NBP) has 4 years of Depreciation and Depletion data on file, last reported at $15000.0 in Q4 2025.

  • Depreciation and Depletion for Q4 2025 came in at $15000.0, down 31.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $74000.0 (down 93.73% YoY), and the FY2025 annual result was $68000.0, down 73.95% from the prior year.
  • Depreciation and Depletion declined to $15000.0 in Q4 2025 per NBP's latest filing, from $17000.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $22000.0 in Q4 2024 and troughed at $15000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 1,395.22
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -1,330.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 NovaBridge Biosciences 328.19 Mn 117.34 Mn - 15,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 15,000.00
Dec 31, 2025 15,000.00
Sep 30, 2025 17,000.00
Sep 30, 2025 17,000.00
Dec 31, 2024 22,000.00
Dec 31, 2024 22,000.00
Sep 30, 2024 20,000.00
Sep 30, 2024 20,000.00
Dec 31, 2020 755,220.95
Dec 31, 2020 755,220.95
Sep 30, 2020 382,291.49
Sep 30, 2020 382,291.49
Dec 31, 2019 425,074.79
Dec 31, 2019 425,074.79